Trial comparing treatments for Pacemaker DDD
Official title Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing
ClinicalTrials.gov ID: NCT05015660
What this study is testing
- What it's testing
- This study aims to find out if left bundle branch pacing is safer and more effective than standard right ventricular pacing.
- Who it's for
- The study is looking for people who have heart block and need a pacemaker.
- What's involved
- Participants will receive a specific type of pacemaker implant and undergo regular heart tests to monitor their condition.
- Time commitment
- The source text does not specify the duration of the study or the required visit schedule.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Patients with an ejection fraction of \>35%
- Third degree AV block
- Symptomatic or asymptomatic second-degree AV block
- First degree AV block ≥ 280ms with a narrow QRS, or ≥ 240ms with an intraventricular delay (QRS duration ≥120ms)
You likely can't join if
- Indication for an implantable cardioverter defibrillator
- Presence of a mechanical tricuspid valve
- Any prior attempt at implantation of an ICD, CRT, HBP, or LBBP
- Lack of capacity to consent
- Other serious medical condition with life expectancy of \<2 years
- Pregnancy
See the full eligibility criteria
- Age ≥ 18 years
- Patients with an ejection fraction of \>35%
- Third degree AV block
- Symptomatic or asymptomatic second-degree AV block
- First degree AV block ≥ 280ms with a narrow QRS, or ≥ 240ms with an intraventricular delay (QRS duration ≥120ms)
- Echocardiogram within the last 3 months, with ability to have DICOM images
- Indication for an implantable cardioverter defibrillator
- Presence of a mechanical tricuspid valve
- Any prior attempt at implantation of an ICD, CRT, HBP, or LBBP
- Lack of capacity to consent
- Other serious medical condition with life expectancy of \<2 years
- Pregnancy
- Patients in whom the conduction system abnormality is expected to be transient or recover over time
- Patients with permanent atrial fibrillation
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.